Unusual Call Options Activity Seen in CG Oncology Stock

Traders buy over 30,000 call options on the biotech company's stock, a 3,313% increase over average daily volume.

Published on Mar. 4, 2026

Got story updates? Submit your updates here. ›

CG Oncology, Inc. (NASDAQ:CGON) saw a significant spike in call options trading on Wednesday, with investors purchasing over 30,000 call options - a 3,313% increase compared to the average daily volume of 882 call options. This unusual options activity suggests traders are bullish on the biotech company's stock.

Why it matters

The surge in call option buying indicates traders are betting on CG Oncology's stock price to rise in the near future. This could signal increased investor confidence in the company's prospects, potentially driven by positive developments in its pipeline of cancer immunotherapies. However, the reasons behind the options activity are not entirely clear and warrant further investigation.

The details

CG Oncology is a clinical-stage biopharmaceutical company focused on developing novel antibody-based immunotherapies for solid tumor cancers. The company's stock has seen significant volatility in recent months, with shares trading between $14.80 and $63.58 over the past 52 weeks.

  • The unusual options activity was observed on Wednesday, March 4, 2026.

The players

CG Oncology, Inc.

A clinical-stage biopharmaceutical company focused on developing novel antibody-based immunotherapies for solid tumor cancers.

James Mulay

A director at CG Oncology who sold 11,145 shares of the company's stock in a transaction on January 9th.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident (San Francisco Chronicle)

“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”

— Gordon Edgar, grocery employee (Instagram)

What’s next

The judge in the case will decide on Tuesday whether or not to allow Walker Reed Quinn out on bail.

The takeaway

This case highlights growing concerns in the community about repeat offenders released on bail, raising questions about bail reform, public safety on SF streets, and if any special laws to govern autonomous vehicles in residential and commercial areas.